Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05506930 · ClinicalTrials.gov registry record · Phase 4

ITM vs QL for Pediatric Open Lower Abdominal Procedures

A Phase 4 study, sponsored by Medical University of South Carolina.

Terminated
Registry status
Phase 4
Development phase
14
Enrollment target

NCT05506930 is a Phase 4 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05506930, a Phase 4 study, was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
Phase 4
Development phase
14 participants
Enrollment target

Study Summary

Patients between the ages of 12 months and 11 years who are undergoing an open lower abdominal procedure will be randomized to receive intrathecal morphine, or bilateral quadratus lumborum block. The investigators will compare the effect that intrathecal morphine and quadratus lumborum blocks have on the duration of pain control as demonstrated by charted pain scores and morphine equivalents in the first 48 hours. This study will also assess the side effects of each intervention such as nausea and vomiting, and itching.

Interventions

  • DRUG Intrathecal Morphine
  • DRUG Quadratus lumborum block

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-08-17
Est. Completion 2024-05-10
Phase Phase 4

What the Registry Record Tells You About NCT05506930

The ClinicalTrials.gov registry entry for NCT05506930 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Intrathecal Morphine is the first listed.

NCT05506930 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05506930 about?

NCT05506930 is a clinical study titled "ITM vs QL for Pediatric Open Lower Abdominal Procedures". Patients between the ages of 12 months and 11 years who are undergoing an open lower abdominal procedure will be randomized to receive intrathecal morphine, or bilateral quadratus lumborum block. The investigators will compare the effect that intrathecal morphine and quadratus lumborum blocks have o...

What is the current status of trial NCT05506930?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2022-08-17. Estimated completion is 2024-05-10.

What interventions are being tested in trial NCT05506930?

The interventions under investigation include: Intrathecal Morphine (DRUG), Quadratus lumborum block (DRUG).

Who is sponsoring clinical trial NCT05506930?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.